MRTX849 is a potent (IC50s = 14 nM NCI-H358, 5 nM MIA PaCa-2) and selective (over 463 proteins 1 µM) covalent KRASG12C inhibitor.1 It showed pronounced tumor regression in 17 of 26 KRASG12C-positive cell lines and xenograft models from multiple tumor
* VAT and and shipping costs not included. Errors and price changes excepted